Caldesmon is necessary for maintaining the actin and intermediate filaments in cultured bladder smooth muscle cells

Cell Motility and the Cytoskeleton

Volumn 64, Issue 12, 2007, Pages 951-965

  Deng, Maoxian ^a   Mohanan, Sunish ^a   Polyak, Erzsebet ^a   Chacko, Samuel ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Actin; Caldesmon; Intermediate filament; Smooth muscle cell

Indexed keywords

ACTIN; CALDESMON; DESMIN; SMALL INTERFERING RNA; TUBULIN; VIMENTIN;

ANIMAL CELL; ARTICLE; BINDING ASSAY; BLADDER MUSCLE; CELL CULTURE; CONTROLLED STUDY; CYTOSKELETON; ELECTRON MICROSCOPY; GENE EXPRESSION; GENE SILENCING; IN VITRO STUDY; INTERMEDIATE FILAMENT; NONHUMAN; PRIORITY JOURNAL; RABBIT; RNA INTERFERENCE; SMOOTH MUSCLE FIBER; STATISTICAL SIGNIFICANCE;

ACTINS; ANIMALS; CALMODULIN-BINDING PROTEINS; CELL LINE; INTERMEDIATE FILAMENTS; MICROFILAMENTS; MUSCLE, SMOOTH; RABBITS; RNA INTERFERENCE; RNA, SMALL INTERFERING; URINARY BLADDER;

EID: 36649025260     PISSN: 08861544     EISSN: 10970169     Source Type: Journal    
DOI: 10.1002/cm.20236     Document Type: Article

References (75)

1. Avrova SV, Borovikov YS, Efimova NN, Chacko S. 1998. Calcium modulates conformational changes in F-actin induced by smooth muscle heavy meromyosin. FEBS Lett 430:266-268.
2. Berner PF, Somlyo AV, Somlyo AP. 1981. Hypertrophy-induced increase of intermediate filaments in vascular smooth muscle. J Cell Biol 88:96-100.
3. Borovikov YS, Avrova SV, Vikhoreva NN, Ermakov VS, Copeland O, Marston SB. 2001. C-terminal actin-binding sites of smooth muscle caldesmon switch actin between conformational states. Int J Biochem Cell Biol 33:1151-1159.
4. Bretscher A. 1986. Thin filament regulatory proteins of smooth- and non-muscle cells. Nature 321:726-727.
5. Bryan J. 1990. Caldesmon - Fragments, sequence, and domain mapping. Ann N Y Acad Sci 599:100-110.
6. Chalovich JM, Hemric ME, Velaz L. 1990. Regulation of ATP hydrolysis by caldesmon. A novel change in the interaction of myosin with actin. Ann N Y Acad Sci 599:85-99.
7. Chang L, Goldman RD. 2004. Intermediate filaments mediate cytoskeletal crosstalk. Nat Rev Mol Cell Biol 5:601-613.
8. Coulombe PA, Wong P. 2004. Cytoplasmic intermediate filaments revealed as dynamic and multipurpose scaffolds. Nat Cell Biol 6:699-706.
9. Czurylo EA. 2000. Motifs of the caldesmon family. Acta Biochim Pol 47:1019-1026.
10. Earley JJ, Su X, Moreland RS. 1998. Caldesmon inhibits active cross-bridges in unstimulated vascular smooth muscle: An antisense oligodeoxynucleotide approach. Circ Res 83:661-667.
11. El-Mezgueldi M, Marston SB. 1996. The effects of smooth muscle calponin on the strong and weak myosin binding sites of F-actin. J Biol Chem 271:28161-28167.
12. El-Mezgueldi M, Copeland O, Fraser ID, Marston SB, Huber PA. 1998. Characterization of the functional properties of smooth muscle caldesmon domain 4a: Evidence for an independent inhibitory actin-tropomyosin binding domain. Biochem J 332:395-401.
13. Eppinga RD, Li Y, Lin JL, Mak AS, Lin JJ. 2006. Requirement of reversible caldesmon phosphorylation at p21-activated kinase-responsive sites for lamellipodia extensions during cell migration. Cell Motil Cytoskeleton 63:543-562.
14. Foster DB, Huang R, Hatch V, Craig R, Graceffa P, Lehman W, Wang CL. 2004. Modes of caldesmon binding to actin: Sites of caldesmon contact and modulation of interactions by phosphorylation. J Biol Chem 279:53387-53394.
15. Fraser ID, Marston SB. 1995. In vitro motility analysis of smooth muscle caldesmon control of actin-tropomyosin filament movement. J Biol Chem 270:19688-19693.
16. Frieden C. 1985. Actin and tubulin polymerization: The use of kinetic methods to determine mechanism. Annu Rev Biophys Biophys Chem 14:189-210.
17. Furst DO, Cross RA, De Mey J, Small JV. 1986. Caldesmon is an elongated, flexible molecule localized in the actomyosin domains of smooth muscle. EMBO J 5:251-257.
18. Ge S, Pachter JS. 2004. Caveolin-1 knockdown by small interfering RNA suppresses responses to the chemokine monocyte chemoattractant protein-1 by human astrocytes. J Biol Chem 279:6688-6695.
19. Grabowski PJ, Black DL. 2001. Alternative RNA splicing in the nervous system. Prog Neurobiol 65:289-308.
20. Graceffa P, Mazurkie A. 2005. Effect of caldesmon on the position and myosin-induced movement of smooth muscle tropomyosin bound to actin. J Biol Chem 280:4135-4143.
21. Graceffa P, Wang CL, Stafford WF. 1988. Caldesmon. Molecular weight and subunit composition by analytical ultracentrifugation. J Biol Chem 263:14196-14202.
22. Haeberle JR, Trybus KM, Hemric ME, Warshaw DM. 1992. The effects of smooth muscle caldesmon on actin filament motility. J Biol Chem 267:23001-23006.
23. Hayashi K, Fujio Y, Kato I, Sobue K. 1991. Structural and functional relationships between h- and l- caldesmons. J Biol Chem 266:355-361.
24. Hayashi K, Saga H, Chimori Y, Kimura K, Yamanaka Y, Sobue K. 1998. Differentiated phenotype of smooth muscle cells depends on signaling pathways through insulin-like growth factors and phosphatidylinositol 3-kinase. J Biol Chem 273:28860-28867.
25. Helfand BT, Chang L, Goldman RD. 2003. The dynamic and motile properties of intermediate filaments. Annu Rev Cell Dev Biol 19:445-467.
26. Herrmann H, Hesse M, Reichenzeller M, Aebi U, Magin TM. 2003. Functional complexity of intermediate filament cytoskeletons: From structure to assembly to gene ablation. Int Rev Cytol 223:83-175.
27. Horiuchi KY, Chacko S. 1988. Interaction between caldesmon and tropomyosin in the presence and absence of smooth muscle actin. Biochemistry 27:8388-8393.
28. Horiuchi KY, Chacko S. 1989. Caldesmon inhibits the cooperative turning-on of the smooth muscle heavy meromyosin by tropomyosin-actin. Biochemistry 28:9111-9116.
29. Horiuchi KY, Wang Z, Chacko S. 1995. Inhibition of smooth muscle actomyosin ATPase by caldesmon is associated with caldesmon-induced conformational changes in tropomyosin bound to actin. Biochemistry 34:16815-16820.
30. Hosoya N, Hosoya H, Yamashiro S, Mohri H, Matsumura F. 1993. Localization of caldesmon and its dephosphorylation during cell division. J Cell Biol 121:1075-1082.
31. Huang R, Wang CL. 2006. A caldesmon peptide activates smooth muscle via a mechanism similar to ERK-mediated phosphorylation. FEBS Lett 580:63-66.
32. Huber PA, Gao Y, Fraser ID, Copeland O, El-Mezgueldi M, Slatter DA, Keane NE, Marston SB, Levine BA. 1998. Structure-activity studies of the regulatory interaction of the 10 kilodalton C-terminal fragment of caldesmon with actin and the effect of mutation of caldesmon residues 691-696. Biochemistry 37:2314-2326.
33. Humphrey MB, Bryan J, Cooper TA, Berget SM. 1995. A 32-nucleotide exon-splicing enhancer regulates usage of competing 5′ splice sites in a differential internal exon. Mol Cell Biol 15:3979-3988.
34. Humphrey MB, Herrera-Sosa H, Gonzalez G, Lee R, Bryan J. 1992. Cloning of cDNAs encoding human caldesmons. Gene 112:197-204.
35. Ishikawa R, Kagami O, Hayashi C, Kohama K. 1992. Characterization of smooth muscle caldesmon as a microtubule-associated protein. Cell Motil Cytoskeleton 23:244-251.
36. Katsuyama H, Wang CL, Morgan KG. 1992. Regulation of vascular smooth muscle tone by caldesmon. J Biol Chem 267:14555-14558.
37. Korn ED. 1982. Actin polymerization and its regulation by proteins from non-muscle cells. Physiol Rev 62:672-737.
38. Leik CE, Willey A, Graham MF, Walsh SW. 2004. Isolation and culture of arterial smooth muscle cells from human placenta. Hypertension 43:837-840.
39. Li Y, Je HD, Malek S, Morgan KG. 2003a. ERK1/2-mediated phosphorylation of myometrial caldesmon during pregnancy and labor. Am J Physiol Regul Integr Comp Physiol 284:R192-R199.
40. Li Y, Wessels D, Wang T, Lin JL, Soll DR, Lin JJ. 2003b. Regulation of caldesmon activity by Cdc2 kinase plays an important role in maintaining membrane cortex integrity during cell division. Cell Mol Life Sci 60:198-211.
41. Li Y, Lin JL, Reiter RS, Daniels K, Soll DR, Lin JJ. 2004. Caldesmon mutant defective in Ca(2+)-calmodulin binding interferes with assembly of stress fibers and affects cell morphology, growth and motility. J Cell Sci 117 (Part 16):3593-3604.
42. Lin VK, Lee IL, McConnell JD. 1992. Expression of nonmuscle-caldesmon in obstruction-induced detrusor hypertrophy is regulated at mRNA level. J Urol 147:314A.
43. Mabuchi K, Lin JJ, Wang CL. 1993. Electron microscopic images suggest both ends of caldesmon interact with actin filaments. J Muscle Res Cell Motil 14:54-64.
44. Makuch R, Kulikova N, Graziewicz MA, Nowak E, Dabrowska R. 1994. Polymerization of actin induced by actin-binding fragments of caldesmon. Biochim Biophys Acta 1206:49-54.
45. Malmqvist U, Arner A, Makuch R, Dabrowska R. 1996. The effects of caldesmon extraction on mechanical properties of skinned smooth muscle fibre preparations. Pflugers Arch 432:241-247.
46. Marston SB, Lehman W. 1985. Caldesmon is a Ca2+-regulatory component of native smooth-muscle thin filaments. Biochem J 231:517-522.
47. Marston SB, Huber PA, Barany M. 1996. Caldesmon. Biochemistry of Smooth Muscle Contraction. San Diego: Academic Press. pp 77-88.
48. Matsumura F, Yamashiro S. 1993. Caldesmon. Curr Opin Cell Biol 5:70-76.
49. Molony L, Hagen PO, Schachat FH. 1986. Intermediate filament heterogeneity in normal and hypercholesterolemic rabbit vascular smooth muscle cells. Exp Cell Res 163:78-86.
50. North AJ, Gimona M, Lando Z, Small JV. 1994. Actin isoform compartments in chicken gizzard smooth muscle cells. J Cell Sci 107 (Part 3):445-455.
51. Numaguchi Y, Huang S, Polte TR, Eichler GS, Wang N, Ingber DE. 2003. Caldesmon-dependent switching between capillary endothelial cell growth and apoptosis through modulation of cell shape and contractility. Angiogenesis 6:55-64.
52. Oishi K, Itoh Y, Isshiki Y, Kai C, Takeda Y, Yamaura K, Ohmuro HT, Uchida MK. 2000. Agonist-induced isometric contraction of smooth muscle cell-populated collagen gel fiber. Am J Physiol Cell Physiol 279:C1432-C1442.
53. Omary MB, Coulombe PA, McLean WH. 2004. Intermediate filament proteins and their associated diseases. N Engl J Med 351:2087-2100.
54. Pfitzer G, Zeugner C, Troschka M, Chalovich JM. 1993. Caldesmon and a 20-kDa actin-binding fragment of caldesmon inhibit tension development in skinned gizzard muscle fiber bundles. Proc Natl Acad Sci USA 90:5904-5908.
55. Pollard TD. 1986. Rate constants for the reactions of ATP- and ADP-actin with the ends of actin filaments. J Cell Biol 103:2747-2754.
56. Polyak E, Standiford DM, Yakopson V, Emerson CP, Jr., Franzini-Armstrong C. 2003. Contribution of myosin rod protein to the structural organization of adult and embryonic muscles in Drosophila. J Mol Biol 331:1077-1091.
57. Sambrook J, Fritsch EF, Maniatis T, Nolan C. 1989. Molecular Cloning: A Laboratory Manual. New York: Cold Spring Harbor.
58. Sanger JM, Mittal B, Dome JS, Sanger JW. 1989. Analysis of cell division using fluorescently labeled actin and myosin in living PtK2 cells. Cell Motil Cytoskeleton 14:201-219.
59. Sato T. 1968. A modified method for lead staining of thin sections. J Electron Microsc (Tokyo) 17:158-159.
60. Shukla AR, Nguyen T, Zheng YM, Zderic SA, DiSanto M, Wein AJ, Chacko S. 2004. Over expression of smooth muscle specific caldesmon by transfection and intermittent agonist induced contraction alters cellular morphology and restores differentiated smooth muscle phenotype. J Urol 171:1949-1954.
61. Sobue K, Muramoto Y, Fujita M, Kakiuchi S. 1981. Purification of a calmodulin-binding protein from chicken gizzard that interacts with F-actin. Proc Natl Acad Sci USA 78:5652-5655.
62. Somlyo AP, Somlyo AV. 1970. Vascular smooth muscle. II. Pharmacology of normal and hypertensive vessels. Pharmacol Rev 22:249-353.
63. Takiguchi K, Matsumura F. 2005. Role of the basic C-terminal half of caldesmon in its regulation of F-actin: Comparison between caldesmon and calponin. J Biochem 138:805-813.
64. Ueki N, Sobue K, Kanda K, Hada T, Higashino K. 1987. Expression of high and low molecular weight caldesmons during phenotypic modulation of smooth muscle cells. Proc Natl Acad Sci USA 84:9049-9053.
65. Wang CL. 2001. Caldesmon and smooth-muscle regulation. Cell Biochem Biophys 35:275-288.
66. Wang CL, Wang LW, Xu SA, Lu RC, Saavedra-Alanis V, Bryan J. 1991. Localization of the calmodulin- and the actin-binding sites of caldesmon. J Biol Chem 266:9166-9172.
67. Wang N, Stamenovic D. 2002. Mechanics of vimentin intermediate filaments. J Muscle Res Cell Motil 23:535-540.
68. Wang Z, Chacko S. 1996. Mutagenesis analysis of functionally important domains within the C-terminal end of smooth muscle caldesmon. J Biol Chem 271:25707-25714.
69. Wang Z, Jiang H, Yang ZQ, Chacko S. 1997a. Both N-terminal myosin-binding and C-terminal actin-binding sites on smooth muscle caldesmon are required for caldesmon-mediated inhibition of actin filament velocity. Proc Natl Acad Sci USA 94:11899-11904.
70. Wang Z, Yang ZQ, Chacko S. 1997b. Functional and structural relationship between the calmodulin- binding, actin-binding, and actomyosin-ATPase inhibitory domains on the C terminus of smooth muscle caldesmon. J Biol Chem 272:16896-16903.
71. Watson MH, Kuhn AE, Novy RE, Lin JJ, Mak AS. 1990. Caldesmon-binding sites on tropomyosin. J Biol Chem 265:18860-18866.
72. Yamashiro S, Chern H, Yamakita Y, Matsumura F. 2001. Mutant caldesmon lacking cdc2 phosphorylation sites delays M-phase entry and inhibits cytokinesis. Mol Biol Cell 12:239-250.
73. Zhang EY, Stein R, Chang S, Zheng Y, Zderic SA, Wein AJ, Chacko S. 2004. Smooth muscle hypertrophy following partial bladder outlet obstruction is associated with overexpression of non-muscle caldesmon. Am J Pathol 164:601-612.
74. Zheng PP, Sieuwerts AM, Luider TM, van der Weiden M, Sillevis-Smitt PA, Kros JM. 2004. Differential expression of splicing variants of the human caldesmon gene (CALD1) in glioma neovascularization versus normal brain microvasculature. Am J Pathol 164:2217-2228.
75. Zheng Y, Weber WT, Wang S, Wein AJ, Zderic SA, Chacko S, DiSanto ME. 2002. Generation of a cell line with smooth muscle phenotype from hypertrophied urinary bladder. Am J Physiol Cell Physiol 283:C373-C382.